- Home
- OPK vs PSEC Comparison
OPK vs PSEC Comparison
Compare OPK & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPK | PSEC |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2011 | 2012 |
Fundamental Metrics
Financial Performance| Metric | OPK | PSEC |
|---|---|---|
| Price | $1.49 | $2.35 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 3 | 1 |
| Target Price | $1.60 | ★ $2.50 |
| AVG Volume (30 Days) | ★ 4.3M | 4.1M |
| Earning Date | 04-28-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 20.07% |
| EPS Growth | N/A | ★ 104.44 |
| EPS | N/A | ★ 0.06 |
| Revenue | ★ $606,879,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.24 | N/A |
| P/E Ratio | ★ N/A | $38.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.98 | $2.11 |
| 52 Week High | $1.73 | $3.13 |
Technical Indicators
Market Signals| Indicator | OPK | PSEC |
|---|---|---|
| Relative Strength Index (RSI) | 62.44 | 56.29 |
| Support Level | $1.26 | $2.15 |
| Resistance Level | $1.55 | $2.35 |
| Average True Range (ATR) | 0.05 | 0.07 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 87.63 | 78.57 |
Price Performance
Historical ComparisonAbout OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About PSEC Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.